Citicoline as Neuroprotector in Neonates Exposed to Hypoxia

• Status: Recruiting
• Trial end date: 2029-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Citicoline as neuroprotector in neonates exposed to hypoxia: A randomized controlled trial

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sherief Abd-Elsalam
• Treatments: Cytidine Diphosphate Choline

Criteria

Inclusion Criteria:

• neonates with hypoxia.

Exclusion Criteria:

• hypoxic ischemic encephalopathy